238 related articles for article (PubMed ID: 31964413)
1. Systemic conditioned medium treatment from interleukin-1 primed mesenchymal stem cells promotes recovery after stroke.
Cunningham CJ; Wong R; Barrington J; Tamburrano S; Pinteaux E; Allan SM
Stem Cell Res Ther; 2020 Jan; 11(1):32. PubMed ID: 31964413
[TBL] [Abstract][Full Text] [Related]
2. Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming.
Redondo-Castro E; Cunningham CJ; Miller J; Brown H; Allan SM; Pinteaux E
Stem Cell Res Ther; 2018 Jan; 9(1):11. PubMed ID: 29343288
[TBL] [Abstract][Full Text] [Related]
3. Hippocampal neuroprotection mediated by secretome of human mesenchymal stem cells against experimental stroke.
Asgari Taei A; Dargahi L; Khodabakhsh P; Kadivar M; Farahmandfar M
CNS Neurosci Ther; 2022 Sep; 28(9):1425-1438. PubMed ID: 35715988
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke.
Cunningham CJ; Redondo-Castro E; Allan SM
J Cereb Blood Flow Metab; 2018 Aug; 38(8):1276-1292. PubMed ID: 29768965
[TBL] [Abstract][Full Text] [Related]
5. Preconditioning with interleukin-1 alpha is required for the neuroprotective properties of mesenchymal stem cells after ischemic stroke in mice.
Wong R; Smith CJ; Allan SM; Pinteaux E
J Cereb Blood Flow Metab; 2023 Dec; 43(12):2040-2048. PubMed ID: 37602422
[TBL] [Abstract][Full Text] [Related]
6. Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression.
Doeppner TR; Herz J; Görgens A; Schlechter J; Ludwig AK; Radtke S; de Miroschedji K; Horn PA; Giebel B; Hermann DM
Stem Cells Transl Med; 2015 Oct; 4(10):1131-43. PubMed ID: 26339036
[TBL] [Abstract][Full Text] [Related]
7. Paracrine Effects of Mesenchymal Stem Cells in Ischemic Stroke: Opportunities and Challenges.
Asgari Taei A; Khodabakhsh P; Nasoohi S; Farahmandfar M; Dargahi L
Mol Neurobiol; 2022 Oct; 59(10):6281-6306. PubMed ID: 35922728
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective Effects of Conditioned Medium of Mesenchymal Stem Cells (MSC-CM) as a Therapy for Ischemic Stroke Recovery: A Systematic Review.
Behzadifard M; Aboutaleb N; Dolatshahi M; Khorramizadeh M; Mirshekari Jahangiri H; Kord Z; Nazarinia D
Neurochem Res; 2023 May; 48(5):1280-1292. PubMed ID: 36581731
[TBL] [Abstract][Full Text] [Related]
9. Human umbilical cord derived mesenchymal stem cells overexpressing HO-1 attenuate neural injury and enhance functional recovery by inhibiting inflammation in stroke mice.
Yang Y; Liu Q; Deng S; Shao Q; Peng L; Ling Y; Huang Y; Zheng S; Jiang Q; Nie D; Chen J
CNS Neurosci Ther; 2024 Feb; 30(2):e14412. PubMed ID: 37592866
[TBL] [Abstract][Full Text] [Related]
10. Recovery of neurological function of ischemic stroke by application of conditioned medium of bone marrow mesenchymal stem cells derived from normal and cerebral ischemia rats.
Tsai MJ; Tsai SK; Hu BR; Liou DY; Huang SL; Huang MC; Huang WC; Cheng H; Huang SS
J Biomed Sci; 2014 Jan; 21(1):5. PubMed ID: 24447306
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stem Cell (MSC)-Derived Extracellular Vesicles Protect from Neonatal Stroke by Interacting with Microglial Cells.
Pathipati P; Lecuyer M; Faustino J; Strivelli J; Phinney DG; Vexler ZS
Neurotherapeutics; 2021 Jul; 18(3):1939-1952. PubMed ID: 34235636
[TBL] [Abstract][Full Text] [Related]
12. The mesenchymal stem cell secretome: A new paradigm towards cell-free therapeutic mode in regenerative medicine.
L PK; Kandoi S; Misra R; S V; K R; Verma RS
Cytokine Growth Factor Rev; 2019 Apr; 46():1-9. PubMed ID: 30954374
[TBL] [Abstract][Full Text] [Related]
13. The effect of Trimetazidine and Diazoxide on immunomodulatory activity of human embryonic stem cell-derived mesenchymal stem cell secretome.
Jahandideh S; Maghsood F; Ghahhari NM; Lotfinia M; Mohammadi M; Johari B; Kadivar M
Tissue Cell; 2017 Oct; 49(5):597-602. PubMed ID: 28843336
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection by Human Dental Pulp Mesenchymal Stem Cells: From Billions to Nano.
Venugopal C; K S; Rai KS; Pinnelli VB; Kutty BM; Dhanushkodi A
Curr Gene Ther; 2018; 18(5):307-323. PubMed ID: 30209999
[TBL] [Abstract][Full Text] [Related]
15. The conditioned medium of human embryonic stem cell-derived mesenchymal stem cells alleviates neurological deficits and improves synaptic recovery in experimental stroke.
Asgari Taei A; Dargahi L; Nasoohi S; Hassanzadeh G; Kadivar M; Farahmandfar M
J Cell Physiol; 2021 Mar; 236(3):1967-1979. PubMed ID: 32730642
[TBL] [Abstract][Full Text] [Related]
16. MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles.
Xin H; Li Y; Liu Z; Wang X; Shang X; Cui Y; Zhang ZG; Chopp M
Stem Cells; 2013 Dec; 31(12):2737-46. PubMed ID: 23630198
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast Growth Factor Type 1 (FGF1)-Overexpressed Adipose-Derived Mesenchaymal Stem Cells (AD-MSC
Ghazavi H; Hoseini SJ; Ebrahimzadeh-Bideskan A; Mashkani B; Mehri S; Ghorbani A; Sadri K; Mahdipour E; Ghasemi F; Forouzanfar F; Hoseini A; Pasdar AR; Sadeghnia HR; Ghayour-Mobarhan M
Stem Cell Rev Rep; 2017 Oct; 13(5):670-685. PubMed ID: 28795363
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells primed with valproate and lithium robustly migrate to infarcted regions and facilitate recovery in a stroke model.
Tsai LK; Wang Z; Munasinghe J; Leng Y; Leeds P; Chuang DM
Stroke; 2011 Oct; 42(10):2932-9. PubMed ID: 21836090
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effects of human embryonic stem cell-derived mesenchymal stem cells secretome preconditioned with diazoxide, trimetazidine and MG-132 on LPS-induced systemic inflammation mouse model.
Jahandideh S; Khatami S; Eslami Far A; Kadivar M
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1178-1187. PubMed ID: 29929400
[TBL] [Abstract][Full Text] [Related]
20. Enhancing the Therapeutic Potential of
Lee S; Kim OJ; Lee KO; Jung H; Oh SH; Kim NK
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
